Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial
Crossref DOI link: https://doi.org/10.1007/s00262-014-1569-0
Published Online: 2014-06-21
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buzzonetti, Alexia
Fossati, Marco
Catzola, Valentina
Scambia, Giovanni
Fattorossi, Andrea
Battaglia, Alessandra
Text and Data Mining valid from 2014-06-21